Skip to main content
Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
8.41
-0.69 (-7.58%)
Mar 6, 2026, 4:00 PM EST - Market closed

Bioventus Revenue

In the year 2025, Bioventus had annual revenue of $568.09M, down -0.91%. Bioventus had revenue of $157.90M in the quarter ending December 31, 2025, with 2.77% growth.

Revenue (ttm)
$568.09M
Revenue Growth
-0.91%
P/S Ratio
0.99
Revenue / Employee
$597,986
Employees
950
Market Cap
563.27M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025568.09M-5.19M-0.91%
Dec 31, 2024573.28M60.94M11.89%
Dec 31, 2023512.35M228.00K0.04%
Dec 31, 2022512.12M81.22M18.85%
Dec 31, 2021430.90M109.74M34.17%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Varex Imaging 854.40M
Orthofix Medical 822.31M
Avanos Medical 701.20M
Tactile Systems Technology 329.52M
Cytek Biosciences 201.49M
SI-BONE 200.93M
Beta Bionics 100.25M
NeuroPace 99.99M
Revenue Rankings

BVS News

More News